Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2011-06-21
2011-06-21
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S273100
Reexamination Certificate
active
07964185
ABSTRACT:
The invention relates to attenuate mutated strains of apicomplex of a family of Sarcocystidae, containing inactivated MIC1 and MIC3 adhesins and to the use thereof for a vaccine.
REFERENCES:
patent: 6248329 (2001-06-01), Chandrashekar et al.
patent: 2 8050466 (2001-08-01), None
Bassuny et al 2003 Infection and Immunity vol. 71 No. 11 pp. 6222-6228.
Meissner et al 2002 Journal of Cell Science 115 pp. 563-574.
Ellis Chapter 29 of Vaccines, Plotkin, et al. (eds) WB Saunders, Philadelphia, 1998, especially p. 571, paragraph 2).
Buxton, D., et al.: “A Commercial Vaccine of Ovine Toxoplasmosis”, Parasitology, Cambridge University Press, London, GB, vol. 110, 1995, pp. S11-S16.
Chartier, C., et al.: “Efficacite Vaccinale de la Souche S48 de Toxoplasama Gondii Vis-à-vis D'Une Infection Experimentale Chez La Chevre”, Annales de Medicine Veterinaire, Faculte de Medecine Veterinaire, Liege, BE, vol. 145, No. 3, 200.1, pp. 202-209.
Montoya, J. G., et al.: Toxoplasmosis, Lancet The, Lancet Limited, London, GB, vol. 363. No. 9425, Jun. 12, 2004, pp. 1965-1976.
Fourmaux, M. N., et al.: “The MIC1 Microneme Protein of Toxoplasma Gondii Contains a Duplicated Receptor-Like Domain and Binds to Host Cell Surface”, Molecular and Biochemical Parasitology Elsevier Science Publishers, Amsterdam, NL, vol. 83, 1996, pp. 201-210.
Bourguin, I., et al.: “Murine Dendtritic Cells Pulsed In Vitro With Toxoplasma Gondii Antigens Induce Protective Immunity In Vivo”, Infection and Immunity, American Society for Microbiology, Washington, US, vol. 66, No. 10, Oct. 1998, pp. 4867-4874.
Dubremetz, J. F.: “Host Celll Invasion by Toxoplasma Gondii”, Trends in Microbiology, Elsevier Science Ltd., Kidlington, GB, vol. 6, No. 1, Jan. 1998, pp. 37-40.
Bhopale, G., et al.: “Development of a Vaccine for Toxoplasmosis: Current Status”, Microbes and Infection, vol. 5, 2003, pp. 457-462.
Bout Daniel
Cerede Odile
Dubremetz Jean-François
Lebrun Maryse
Soête Martine
Archie Nina A
Centre National de la Recherche Scientifique
Institut National de la Recherche Agronomique
Morgan & Lewis & Bockius, LLP
Universite Francois Rabelais
LandOfFree
Apicomplex vaccine strains of a family of Sarcocystidae does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apicomplex vaccine strains of a family of Sarcocystidae, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apicomplex vaccine strains of a family of Sarcocystidae will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2630833